CAS 1356841-18-3

Formule : C17H28N2O5

InChI : InChI=1S/C17H28N2O5/c1-3-6-12(16(21)22)18-10(2)15(20)19-13-8-5-4-7-11(13)9-14(19)17(23)24/h10-14,18H,3-9H2,1-2H3,(H,21,22)(H,23,24)/t10-,11-,12-,13-,14-/m0/s1/i2D3,10D

Code InChI : ODAIHABQVKJNIY-NREMRFMJSA-N

SMILES : [2H][C@@](C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O)(C([2H])([2H])[2H])N[C@@H](CCC)C(=O)O

Perindopril EP Impurity B-d4 (Perindopril USP Related Compound B-d4 (Free Hydrate), Perindoprilat-d4)

CAS : 1356841-18-3

Formule : C₁₇H₂₄D₄N₂O₅

Couleur et forme : White To Off-White Solid

Masse moléculaire : 344.44

Ref: 4Z-P-066

Perindoprilat-d4 (Mixture of Diastereomers)

Produit contrôlé

CAS : 1356841-18-3, 95153-31-4

Applications Perindoprilat-d4 is the isotope labelled analog of Perindoprilat (P287531); an angiotensin-converting enzyme (ACE) inhibitor and antihypertensive.
References Pascard, C., et al.: J. Med. Chem., 34, 663 (1991)

Formule : C₁₇H₂₄D₄N₂O₅

Couleur et forme : Neat

Masse moléculaire : 344.44

Ref: TR-P287534

Perindoprilat-D4

CAS : 1356841-18-3

Perindoprilat-D4 is a deuterated compound of Perindoprilat. Perindoprilat (T1484) has a CAS number of 95153-31-4. Perindoprilat (T1484) is an angiotensin-converting enzyme inhibitor.

Formule : C₁₇H₂₄D₄N₂O₅

Masse moléculaire : 344.44

Ref: TM-TMIJ-0177

Perindoprilat-[d4] acetate

CAS : 1356841-18-3

Formule : C₁₇H₂₈N₂O₅

Masse moléculaire : 344.4

Ref: BE-MD-7328

Perindoprilat-d4

CAS : 1356841-18-3

Formule : C₁₇H₂₈N₂O₅

Masse moléculaire : 344.4

Ref: BE-RMCP101054

Perindoprilat-d4

CAS : 1356841-18-3

Formule : C₁₇H₂₈N₂O₅

Masse moléculaire : 344.4

Ref: BE-RMCP16075

Perindoprilat-d4

CAS : 1356841-18-3

Perindoprilat-d4 is a medicinal compound that has been extensively studied for its potential use in cancer treatment. It has been shown to induce apoptosis, or programmed cell death, in a variety of cancer cell lines. Perindoprilat-d4 also inhibits the activity of certain kinases, which are enzymes that play a key role in regulating the cell cycle and promoting cell growth. This inhibition leads to a disruption of the normal cell cycle and ultimately results in cell death. In addition to its anti-cancer properties, Perindoprilat-d4 has also been shown to have potential therapeutic applications in other diseases where kinase inhibitors may be beneficial, such as autoimmune disorders or inflammatory conditions. Its effectiveness has been demonstrated in both human and Chinese hamster ovary cells, making it a promising candidate for further research into novel cancer treatments.

Formule : C₁₇H₂₈N₂O₅

Degré de pureté : Min. 95%

Masse moléculaire : 344.4 g/mol

Ref: 3D-GEC84118

Perindoprilat-d4

CAS : 1356841-18-3

Formule : C₁₇H₂₄D₄N₂O₅

Masse moléculaire : 344.4

Ref: ST-EA-CP-IL0286